Sign in to continue:

Saturday, March 7th, 2026

China Life Insurance Company Limited Announces Board Meeting to Approve 2025 Final Results and Dividend on March 25, 2026 1

China Life Insurance Company Limited Announces Upcoming Board Meeting – Key Details for Investors

China Life Insurance Company Limited Schedules Board Meeting to Approve 2025 Annual Results and Final Dividend

Key Points for Investors

  • Date of Board Meeting: China Life Insurance Company Limited (“China Life”, Stock Code: 2628) has announced that its Board of Directors will convene a meeting on Wednesday, 25 March 2026.
  • Purpose of the Meeting: The primary agenda is to review and approve the Company’s final results for the financial year ended 31 December 2025. Additionally, the Board will deliberate on the recommendation of a final dividend for shareholders.
  • Other Business: The Board may also transact any other business matters during this meeting.

Significant Information for Shareholders

  • Potential Price Sensitivity: The announcement of the Company’s annual results and any final dividend recommendation are typically highly price sensitive events. Investors often react strongly to these disclosures, which can significantly impact the share price.
  • Dividend Expectations: The final dividend recommendation, if approved, will directly affect shareholder returns. Investors seeking income should closely monitor the outcome of this meeting.
  • Corporate Governance: The announcement also provides a full list of current Board members, including Executive Directors (Cai Xiliang, Li Mingguang, Liu Hui, Ruan Qi), Non-executive Directors (Hu Jin, Hu Rong, Niu Kailong), and Independent Non-executive Directors (Lam Chi Kuen, Zhai Haitao, Chen Jie, Lu Feng). This serves as a reminder of the Company’s governance structure and may interest investors focused on board composition.

What Investors Should Watch

The upcoming Board meeting is a key corporate event for China Life Insurance Company Limited. The review and approval of annual results will provide insights into the Company’s financial health, performance trends, and future outlook. The final dividend proposal, if any, will determine the level of direct returns to shareholders for the year. Given the importance of these announcements, the meeting outcome is likely to be a major driver of the stock’s short-term price movement. Investors are advised to pay close attention to subsequent disclosures following the meeting.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should review the Company’s official announcements and consult with professional advisers before making any investment decisions.


View CHINA LIFE Historical chart here



GenFleet’s GFH375 Receives Breakthrough Therapy Designation in China for KRAS G12D-Mutant NSCLC Treatment

GenFleet Therapeutics Granted Breakthrough Therapy Designation for KRAS G12D Inhibitor in NSCLC GenFleet Therapeutics Achieves Breakthrough Therapy Designation for KRAS G12D Inhibitor in China – A Potential Value Driver for Investors Key Highlights GenFleet...

Chinese Estates Holdings Limited Announces Board Meeting for Final Results and Dividend Consideration on 9 March 2026

Chinese Estates Holdings Limited Announces Upcoming Board Meeting for 2025 Final Results Chinese Estates Holdings Limited Schedules Board Meeting to Approve 2025 Final Results and Dividend Recommendation Key Points for Investors: Board Meeting Date:...

Greentech Technology International Limited Expects Over HK$60 Million Profit for HY2025 and 100% FY2024 Profit Increase Amid Trading Suspension 12

Greentech Technology International Limited Issues Positive Profit Alert Greentech Technology International Limited Issues Major Profit Alert: Sharp Increase Expected for HY2025 and FY2024 Key Highlights Significant Profit Growth Expected: The Group anticipates profit attributable...

   Ad